- Ticker
- ACXP
- Price
- 1.91
- Stock movement down
- -0.02 (-1.04%)
- Company name
- Acurx Pharmaceuticals LLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 22.22M
- Ent value
- 15.17M
- Price/Sales
- -
- Price/Book
- 3.04
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -45.89%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-04-08
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ACXP does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 3.04 |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 11.64M |
| EPS (TTM) | -2.04 |
| FCF per share (TTM) | -1.34 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -8.83M |
| Net income (TTM) | -17.38M |
| EPS (TTM) | -2.04 |
| EPS (1y forward) | -1.14 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 9.11M |
| Net receivables | 0.00 |
| Total current assets | 9.11M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 9.38M |
| Accounts payable | 2.06M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.06M |
| Total liabilities | 2.06M |
| Shareholder's equity | 7.32M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -11.41M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -11.41M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -237.66% |
| Return on Assets | -185.40% |
| Return on Invested Capital | -237.66% |
| Cash Return on Invested Capital | -155.97% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.91 |
| Daily high | 1.99 |
| Daily low | 1.86 |
| Daily Volume | 77K |
| All-time high | 7.89 |
| 1y analyst estimate | 13.33 |
| Beta | - |
| EPS (TTM) | -2.04 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 10 May 2024 |
Downside potential
Loading...
Downside potential data
| ACXP | S&P500 | |
| Current price drop from All-time high | -75.79% | -0.85% |
| Highest price drop | -83.78% | -56.47% |
| Date of highest drop | 3 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -54.03% | -11.35% |
| Avg time to new high | 701 days | 13 days |
| Max time to new high | 700 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
22.22M
Marketcap category
Small-cap
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page